220 related articles for article (PubMed ID: 19198654)
1. A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni.
Caffrey CR; Rohwer A; Oellien F; Marhöfer RJ; Braschi S; Oliveira G; McKerrow JH; Selzer PM
PLoS One; 2009; 4(2):e4413. PubMed ID: 19198654
[TBL] [Abstract][Full Text] [Related]
2. In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni.
Neves BJ; Braga RC; Bezerra JC; Cravo PV; Andrade CH
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3435. PubMed ID: 25569258
[TBL] [Abstract][Full Text] [Related]
3. Large-scale RNAi screening uncovers therapeutic targets in the parasite
Wang J; Paz C; Padalino G; Coghlan A; Lu Z; Gradinaru I; Collins JNR; Berriman M; Hoffmann KF; Collins JJ
Science; 2020 Sep; 369(6511):1649-1653. PubMed ID: 32973031
[TBL] [Abstract][Full Text] [Related]
4. The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite's biology.
Silva LL; Marcet-Houben M; Nahum LA; Zerlotini A; Gabaldón T; Oliveira G
BMC Genomics; 2012 Nov; 13():617. PubMed ID: 23148687
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni.
Sanchez MC; Cupit PM; Bu L; Cunningham C
Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180
[TBL] [Abstract][Full Text] [Related]
6. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.
Padalino G; Ferla S; Brancale A; Chalmers IW; Hoffmann KF
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):559-570. PubMed ID: 30455056
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma mansoni genome: closing in on a final gene set.
Haas BJ; Berriman M; Hirai H; Cerqueira GG; Loverde PT; El-Sayed NM
Exp Parasitol; 2007 Nov; 117(3):225-8. PubMed ID: 17643433
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni.
Verjovski-Almeida S; DeMarco R; Martins EA; Guimarães PE; Ojopi EP; Paquola AC; Piazza JP; Nishiyama MY; Kitajima JP; Adamson RE; Ashton PD; Bonaldo MF; Coulson PS; Dillon GP; Farias LP; Gregorio SP; Ho PL; Leite RA; Malaquias LC; Marques RC; Miyasato PA; Nascimento AL; Ohlweiler FP; Reis EM; Ribeiro MA; Sá RG; Stukart GC; Soares MB; Gargioni C; Kawano T; Rodrigues V; Madeira AM; Wilson RA; Menck CF; Setubal JC; Leite LC; Dias-Neto E
Nat Genet; 2003 Oct; 35(2):148-57. PubMed ID: 12973350
[TBL] [Abstract][Full Text] [Related]
9. The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development.
Ziniel PD; Karumudi B; Barnard AH; Fisher EM; Thatcher GR; Podust LM; Williams DL
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004279. PubMed ID: 26713732
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
Leow CY; Willis C; Leow CH; Hofmann A; Jones M
Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme.
Jacques SA; Kuhn I; Koniev O; Schuber F; Lund FE; Wagner A; Muller-Steffner H; Kellenberger E
J Med Chem; 2015 Apr; 58(8):3582-92. PubMed ID: 25803425
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni.
Hahnel S; Wheeler N; Lu Z; Wangwiwatsin A; McVeigh P; Maule A; Berriman M; Day T; Ribeiro P; Grevelding CG
PLoS Pathog; 2018 Jan; 14(1):e1006718. PubMed ID: 29346437
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni genome project: an update.
LoVerde PT; Hirai H; Merrick JM; Lee NH; El-Sayed N
Parasitol Int; 2004 Jun; 53(2):183-92. PubMed ID: 15081950
[TBL] [Abstract][Full Text] [Related]
14. [Schistosoma mansoni receptor tyrosine kinases: towards new therapeutic targets].
Vicogne J; Dissous C
J Soc Biol; 2003; 197(4):367-73. PubMed ID: 15005518
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni Larval Extracellular Vesicle protein 1 (SmLEV1) is an immunogenic antigen found in EVs released from pre-acetabular glands of invading cercariae.
Gasan TA; Kuipers ME; Roberts GH; Padalino G; Forde-Thomas JE; Wilson S; Wawrzyniak J; Tukahebwa EM; Hoffmann KF; Chalmers IW
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009981. PubMed ID: 34793443
[TBL] [Abstract][Full Text] [Related]
16. Impact of transposable elements in the architecture of genes of the human parasite Schistosoma mansoni.
Philippsen GS; DeMarco R
Mol Biochem Parasitol; 2019 Mar; 228():27-31. PubMed ID: 30597185
[TBL] [Abstract][Full Text] [Related]
17. Uncovering Notch pathway in the parasitic flatworm Schistosoma mansoni.
Magalhães LG; Morais ER; Machado CB; Gomes MS; Cabral FJ; Souza JM; Soares CS; Sá RG; Castro-Borges W; Rodrigues V
Parasitol Res; 2016 Oct; 115(10):3951-61. PubMed ID: 27344453
[TBL] [Abstract][Full Text] [Related]
18. Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.
Kasinathan RS; Goronga T; Messerli SM; Webb TR; Greenberg RM
FASEB J; 2010 Jan; 24(1):128-35. PubMed ID: 19726755
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
Lamberton PHL; Faust CL; Webster JP
Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
[TBL] [Abstract][Full Text] [Related]
20. RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.
Stefanić S; Dvořák J; Horn M; Braschi S; Sojka D; Ruelas DS; Suzuki B; Lim KC; Hopkins SD; McKerrow JH; Caffrey CR
PLoS Negl Trop Dis; 2010 Oct; 4(10):e850. PubMed ID: 20976050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]